-
-
Login
Novo Nordisk is adopting the shorter name ‘Novo’ as part of a major global rebrand. Behind the new logo is a wider shift in how one of diabetes’s oldest companies sees healthcare, patients and an increasingly consumer-driven market.
New research analysing almost 47 million CGM readings reveals how often glucose reaches a sensor's measurement limits, how long it can remain there and what that means for the information we see.
